alpha-aminopyridine has been researched along with Kidney Failure in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Lagampan, C; Parinyanitikul, N; Poovorawan, N | 1 |
| Canas, GC; Ginman, K; Gong, J; LaBadie, RR; Lin, S; Pelletier, K; Pithavala, YK; Winkle, P | 1 |
| Chakraborty, A; Ji, Y; Miller, M; Quinlan, M; Serra, P; Wang, Y; Yartsev, V | 1 |
| Chen, J; Houk, B; Pithavala, YK; Ruiz-Garcia, A | 1 |
| Chen, J; Lin, T; Majumdar, T; Meyers, D; Mita, S; Pal, P; Rebello, S; Sunkara, G | 1 |
| Albrecht-Küpper, B; Dinh, W; Gheorghiade, M; Sabbah, HN; van der Laan, M; Voors, AA | 1 |
| Bethke, TD; Gleiter, CH; Hartmann, M; Hünnemeyer, A; Lahu, G | 1 |
| Chuang, PY; Deng, Y; He, JC; Klotman, PE; Liu, R; Mallipattu, SK; Wu, Y; Zhong, Y | 1 |
| Ray, PE | 1 |
1 review(s) available for alpha-aminopyridine and Kidney Failure
| Article | Year |
|---|---|
Partial Adenosine A1 Agonist in Heart Failure.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles | 2017 |
5 trial(s) available for alpha-aminopyridine and Kidney Failure
| Article | Year |
|---|---|
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment.
Topics: Adult; Aminopyridines; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Humans; Lactams; Lung Neoplasms; Pyrazoles; Renal Insufficiency | 2022 |
Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: An Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical Trials.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Purines; Renal Insufficiency | 2023 |
Population pharmacokinetic model with time-varying clearance for lorlatinib using pooled data from patients with non-small cell lung cancer and healthy participants.
Topics: Adult; Aminopyridines; Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Female; Healthy Volunteers; Hepatic Insufficiency; Humans; Lactams; Lung Neoplasms; Male; Middle Aged; Prognosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proton Pump Inhibitors; Pyrazoles; Renal Insufficiency; Serum Albumin | 2021 |
Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor.
Topics: Acetates; Aged; Aminopyridines; Body Mass Index; Case-Control Studies; Diacylglycerol O-Acyltransferase; Enzyme Inhibitors; Female; Humans; Hyperlipoproteinemia Type I; Male; Middle Aged; Protein Binding; Renal Insufficiency | 2015 |
Influence of renal impairment on the pharmacokinetics of oral roflumilast: an open-label, parallel-group, single-center study.
Topics: Administration, Oral; Adult; Aminopyridines; Area Under Curve; Benzamides; Case-Control Studies; Creatinine; Cyclopropanes; Female; Half-Life; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Prospective Studies; Renal Insufficiency; Severity of Illness Index | 2011 |
3 other study(ies) available for alpha-aminopyridine and Kidney Failure
| Article | Year |
|---|---|
Lactic acidosis, a potential toxicity from drug-drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report.
Topics: Acidosis, Lactic; Aminopyridines; Breast Neoplasms; Drug Interactions; Female; Fulvestrant; Humans; Metformin; Middle Aged; Purines; Renal Insufficiency | 2022 |
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure.
Topics: AIDS-Associated Nephropathy; Aminopyridines; Animals; Benzamides; Benzoates; Cell Differentiation; CREB-Binding Protein; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclopropanes; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Kidney Tubules; Male; Mice; Mice, Transgenic; Phosphodiesterase 4 Inhibitors; Phosphorylation; Proteinuria; Receptors, Retinoic Acid; Renal Insufficiency; Retinoic Acid Receptor alpha; Signal Transduction; Tetrahydronaphthalenes; Time Factors | 2012 |
Can we cure HIV-1-associated nephropathy in transgenic mice?
Topics: AIDS-Associated Nephropathy; Aminopyridines; Animals; Benzamides; Benzoates; Cyclopropanes; Female; HIV Infections; HIV-1; Kidney Tubules; Male; Phosphodiesterase 4 Inhibitors; Renal Insufficiency; Tetrahydronaphthalenes | 2012 |